DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Diamant M, Van Gaal L, Guerci B et al.
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open label randomised trial.
Lancet Diab Endocrinol 2014;
2: 464-473
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.